Chong Kun Dang Pharmaceutical: all 299 studies

Page 2 of 3. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.Status unknownNCT04700709Phase 4
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)CompletedNCT04694989Phase 1
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT04678388Phase 1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy SubjectsStatus unknownNCT04676893Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386CompletedNCT04673864Phase 1
• A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344Status unknownNCT04673695Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845CompletedNCT04673682Phase 1
• The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard TherapyStatus unknownNCT04667975Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348CompletedNCT04660370Phase 1
• Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed ConditionsStatus unknownNCT04651881Phase 1
• A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 PneumoniaCompletedNCT04628143Phase 2
• A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy VolunteersStatus unknownNCT04627207Phase 1
• A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 PneumoniaCompletedNCT04623021Phase 2
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy VolunteersStatus unknownNCT04611932Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348CompletedNCT04587206Phase 1
• Study to Evaluate the Efficacy and Safety of CKD-352CompletedNCT04548427Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B PatientsCompletedNCT04539652Phase 4
• A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedNCT04521023Phase 4
• Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mgCompletedNCT04511000Phase 4
• Evaluation of the Safety and Tolerability of CKD-508 in Healthy SubjectsCompletedNCT04488900Phase 1
• Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersStatus unknownNCT04478097Phase 1
• Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.CompletedNCT04471441Phase 4
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351Status unknownNCT04448223Phase 2
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)CompletedNCT04431687Phase 1
• Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) TabletStatus unknownNCT04388215Phase 3
• Compare the Pharmacokinetics and Safety of CKD-391CompletedNCT04354987Phase 1
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150CompletedNCT04334213Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389Status unknownNCT04322032Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-386CompletedNCT04312698Phase 3
• Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy VolunteersCompletedNCT04304547Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy VolunteersCompletedNCT04272502Phase 1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy SubjectsCompletedNCT04260438Phase 1
• A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348CompletedNCT04258865Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495CompletedNCT04255589Phase 3
• A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396Status unknownNCT04246190Phase 1
• Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)Status unknownNCT04224350Phase 4
• A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult VolunteersStatus unknownNCT04223895Phase 1
• A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375Status unknownNCT04221360Phase 1
• A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT04204603Phase 2
• Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1CompletedNCT04156685Phase 1
• Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.CompletedNCT04102943Phase 4
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)CompletedNCT04083872Phase 1
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)CompletedNCT04083846Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy VolunteersCompletedNCT04075643Phase 1
• Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)Status unknownNCT04069065Phase 4
• A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012Status unknownNCT04035538Phase 1
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy VolunteersCompletedNCT04019743Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial FibrillationStatus unknownNCT03950843Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mgCompletedNCT03928470Phase 4
• A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male VolunteersStatus unknownNCT03920579Phase 1
• Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After MealCompletedNCT03887871Phase 1
• Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy VolunteersCompletedNCT03887858Phase 1
• Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy VolunteersCompletedNCT03868072Phase 1
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy VolunteersCompletedNCT03858725Phase 1
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy AdultsStatus unknownNCT03849495Phase 1
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed ConditionStatus unknownNCT03849339Phase 1
• Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male AdultsStatus unknownNCT03849287Phase 1
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy AdultsStatus unknownNCT03849261Phase 1
• The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375Status unknownNCT03848637Phase 1
• A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355CompletedNCT03802162Phase 1
• Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
• Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337CompletedNCT03793985Phase 1
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351Status unknownNCT03762369Phase 3
• Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant RecipientsCompletedNCT03749356Phase 4
• Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy VolunteersStatus unknownNCT03748212Phase 1
• Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesCompletedNCT03739125Phase 3
• The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed ConditionCompletedNCT03738449Phase 1
• A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy SubjectsStatus unknownNCT03726866Phase 1
• The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497CompletedNCT03726853Phase 2
• CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female SubjectsStatus unknownNCT03713892Phase 1
• Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy VolunteersCompletedNCT03671941Phase 1
• Pharmacokinetics and Safety Profile of CKD-333CompletedNCT03659149Phase 1
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy AdultsStatus unknownNCT03646799Phase 1
• The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 DiabetesStatus unknownNCT03641352Phase 3
• Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesStatus unknownNCT03627182Phase 3
• Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308CompletedNCT03616392Phase 1
• A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male SubjectsCompletedNCT03609606Phase 1
• Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mgStatus unknownNCT03601910Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 TabletCompletedNCT03583905Phase 3
• CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)CompletedNCT03569579Phase 1
• A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy SubjectsCompletedNCT03558425Phase 1
• A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male SubjectsCompletedNCT03444402Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 TabletCompletedNCT03437785Phase 2
• CKD-11101 Phase 3 SC StudyCompletedNCT03431623Phase 3
• CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving HemodialysisCompletedNCT03428594Phase 3
• A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337CompletedNCT03382756Phase 1
• A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337CompletedNCT03346187Phase 1
• Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia PatientsCompletedNCT03246880Phase 3
• CKD-841 Pharmacokinetic/Pharmacodynamic StudyCompletedNCT03233932Phase 1
• A Study to Compare PK, PD and Safety of CKD-381 in Healthy SubjectsCompletedNCT03211143Phase 1
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedNCT03210649Phase 1
• Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male SubjectsCompletedNCT03175835Phase 1
• CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple MyelomaStatus unknownNCT03150316Phase 1
• A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.Status unknownNCT03076957Phase 1/2
• Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once DailyStatus unknownNCT03067415Phase 2
• The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis PatientsCompletedNCT03067194Phase 4
• Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart FailureStatus unknownNCT03063697
• CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple MyelomaStatus unknownNCT03051841Phase 1
• The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930CompletedNCT03034486Phase 1
• Pharmacokinetic Drug-drug Interaction of CKD-330 and D086CompletedNCT03017950Phase 1

← Chong Kun Dang Pharmaceutical overview and focus areas